Ataxin-7 ASO reduced retinal ATXN7 expression and protein aggregation, improved cone and rod photoreceptor function and gene expression, and rescued retinal degeneration, achieving a significant beneficial therapeutic response in symptomatic mice. CAG ASO transiently improves retinal disease phenotype. The gene discussed is ATXN7; the disease is retinal degeneration.